Revamping Medical Regulations: A Call for Comprehensive Reform

By HEOR Staff Writer

November 16, 2023

The Regulatory Hurdle

Europe’s healthcare system, known for its extensive social security and fair healthcare access, faces a test of strength. Structural barriers in the existing regulatory framework hinder the prompt distribution of vital medical technologies. These technologies are crucial at every patient care stage.


The In Vitro Diagnostic Medical Devices Regulation (IVDR) and Medical Devices Regulation (MDR) were designed with the objective of creating a robust, transparent, predictable, and sustainable regulatory system for medical devices. The expectation was that these regulations would foster innovation while ensuring high levels of safety and health. However, more than half a decade into their implementation, the IVDR and MDR have fallen short of achieving these goals. The result is a sluggish, unpredictable, costly, and intricate process.

The Call for Medical Device Regulations Reform

MedTech Europe, a prominent representative of the medical technology industry, advocates for a comprehensive overhaul of the regulations to make them more beneficial for patients and European health systems. This reform should focus on three main areas: efficiency, innovation, and governance.

Efficiency: MedTech Europe suggests a more streamlined and cost-effective CE marking system. This system should enhance predictability, lessen administrative burdens, and be adaptable to external changes.

Innovation: The implementation of an innovation principle is advised. This would expedite the integration of the latest medical technologies into European healthcare systems, through the use of specific assessment pathways and early dialogues with developers.

Governance: The creation of a singular, dedicated structure to supervise and manage the regulatory system is recommended. This structure should have the power to make decisions at the system level.

Conclusion

To ensure that Europe maintains its high standards of care, and continues to leverage innovative medical technology, it is crucial to reform the existing regulatory framework. The solutions proposed by MedTech Europe provide a starting point for discussions among all stakeholders, with the aim of addressing the current challenges and reshaping the future of Europe’s healthcare system.

Reference url

Recent Posts

Innovations in Haematology Cell Therapy at ASH 2025

By HEOR Staff Writer

December 5, 2025

Advancing Haematology Cell Therapy Innovations at ASH 2025 AstraZeneca is significantly advancing haematology cell therapy with its largest-ever presence at the 67th American Society of Hematology (ASH) Annual Meeting and E...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft Annual Work Programm...

By João L. Carapinha

December 4, 2025

How will the EU Health Technology Assessment framework evolve in 2026 to improve clinical evaluations for cancer treatments and advanced therapies? The EU Health Technology Assessment (HTA) initiative coordinates standardized reviews of medicines and devices across Member States, thereby boosting...
WHO Guidelines Set New Standard for GLP-1 Obesity Therapies in Adults
What does the latest WHO guideline reveal about GLP-1 obesity therapies, as released in December 2025? This landmark document establishes the first global standards for integrating glucagon-like peptide-1 (GLP-1) receptor agonists and GIP/GLP-1 dual agonists into chronic obesity management, treat...